Wegovy (semaglutide) is an FDA-approved prescription medication for chronic weight management in adults and children 12 years and older with obesity (BMI of 30 or more) and overweight (BMI of 27 or more) with at least one weight-related condition, such as type 2 diabetes, high cholesterol, or high blood pressure
After 30 days on the 1.5 mg dose, increase the dose to 4 mg once daily
The natural form of GLP-1 only lasts minutes in the body before being broken down
Clinical trials show that Mounjaro is associated with greater weight loss
This minireview describes the molecular mechanisms of semaglutide and liraglutide in different metabolic pathways, and its mechanism of action in processes such as appetite regulation, insulin secretion, glucose homeostasis, energy expenditure, and lipid metabolism